Crescent Biopharma, Inc. (CBIO)

Crescent Biopharma Revenue

Crescent Biopharma had revenue of $1.04M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $11.88M. In the year 2025, Crescent Biopharma had annual revenue of $10.84M.

• Revenue (ttm): $11.88M
• Revenue Growth: n/a
• P/S Ratio: 58.00
• Revenue / Employee: $216,055
• Employees: 55
• Market Cap: 689.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.84M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	10.00K	-65.00K	-86.67%
Dec 31, 2022	75.00K	-1.08M	-93.53%
Dec 31, 2021	1.16M	-9.00M	-88.59%
Dec 31, 2020	10.16M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	18.50M	-1.57M	-7.83%
Dec 31, 2015	20.07M	5.04M	33.56%
Dec 31, 2014	15.03M	11.03M	276.37%
Dec 31, 2013	3.99M	-11.26M	-73.83%
Dec 31, 2012	15.26M	11.44M	300.05%
Dec 31, 2011	3.81M	-	-

Data Source: Fiscal.ai Last updated: Apr 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error